欧洲基因检测市场按检测类型和国家划分 - 分析与预测（2024-2033）

预计2024年欧洲基因检测市场价值将达71.3亿美元。

预计到 2034 年，市场规模将达到 210.6 亿美元，2024-2034 年预测期内的复合年增长率为 12.79%。由于技术的不断改进，欧洲市场正在迅速扩张。基因定序技术的进步，尤其是次世代定序（NGS），使得基因检测更加准确、有效率且经济实惠。随着医疗专业人员和公众对基因检测对于遗传疾病的诊断和治疗的益处的认识不断提高，需求也随之增加。此外，遗传疾病和遗传性癌症发生率的上升凸显了早期诊断和个人化治疗方案的必要性。产前检测、新生儿筛检、肿瘤学和精准医疗等基因检测的应用不断扩大，进一步推动了市场的成长。监管支持和协调的欧洲指导方针保证了基因检测的品质和可靠性，促进了整个全部区域的市场扩张。

由于基因序列测定技术的发展、人们认识的不断提高以及个人化医疗需求的不断增加，欧洲基因检测市场正在迅速成长。基因检测对于诊断遗传疾病、检测遗传疾病倾向以及促进罕见遗传疾病、囊肿纤维化和遗传性癌症的早期疗育至关重要。

次世代定序（NGS）技术的广泛应用大大提高了基因检测的准确性、有效性和可负担性，使患者和医疗保健专业人员更容易获得基因检测。政府支持新生儿筛检和携带者检测计划的倡议、有利的法律规范和报销政策进一步推动了市场扩张。

遗传疾病和遗传性癌症的发生率不断上升，推动了对全面检测解决方案的需求。此外，直接面向消费者（DTC）的基因检测服务正变得越来越受欢迎，这种服务允许人们无需医生处方笺即可获得基因资讯。在生殖健康测试、肿瘤遗传学和个人化医疗方面的大量投资正在进一步扩大市场范围。

只要欧洲继续优先考虑精准医疗和早期疾病检测，基因检测市场预计将稳定成长。预计技术进步、监管协调和公众意识的提高将推动这一成长。

本报告研究了欧洲基因检测市场，提供了市场概况以及基因检测类型、国家和公司概况的趋势。

目录

执行摘要

第 1 章 基因检测：产业展望

• 基因检测现况
• 市场足迹与未来潜力
• 趋势：当前和未来的影响评估
• 研发回顾
• 市场整体规模及渗透率
• 法律和监管框架
• 赎回情况
• 市场动态

第二章 区域

• 驱动因素与限制因素
• 欧洲

第三章 市场竞争基准化分析与公司概况

• 竞争格局
  • 关键策略和发展
  • 企业市场占有率分析
• 公司简介
  • Centogene AG
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd

第四章调查方法

Introduction to Europe Hereditary Genetic Testing Market

The Europe hereditary genetic testing market was valued at $7.13 billion in 2024 and is anticipated to reach $21.06 billion by 2034, witnessing a CAGR of 12.79% during the forecast period 2024-2034. The market in Europe is expanding rapidly due to continuous technological improvements. Genetic testing is now more accurate, efficient, and affordable thanks to advancements in genetic sequencing technologies, especially next-generation sequencing (NGS). Demand is being driven by growing awareness of the advantages of genetic testing for diagnosing and treating hereditary conditions among healthcare professionals and the public. Additionally, the need for early diagnosis and individualized treatment solutions is highlighted by the rising incidence of genetic disorders and hereditary cancers. The expanding applications of genetic testing, such as prenatal and newborn screening, oncology, and precision medicine, further bolster the market's growth. The quality and dependability of genetic tests are guaranteed by regulatory support and harmonized European guidelines, which promote market expansion throughout the region.

Market Introduction

The market for hereditary genetic testing in Europe is growing quickly due to developments in genetic sequencing technologies, rising awareness, and a growing need for individualized medical care. In order to diagnose inherited disorders, detect genetic disease predispositions, and facilitate early interventions for conditions like rare genetic disorders, cystic fibrosis, and hereditary cancers, hereditary genetic testing is essential.

The accuracy, effectiveness, and affordability of genetic tests have increased dramatically with the widespread use of next-generation sequencing (NGS) technologies, opening up access to them for patients and healthcare professionals alike. Further propelling market expansion are government initiatives supporting newborn screening and carrier testing programs, as well as advantageous regulatory frameworks and reimbursement policies.

The rising incidence of genetic disorders and hereditary cancers is driving demand for comprehensive testing solutions. Additionally growing in popularity are direct-to-consumer (DTC) genetic testing services, which give people access to genetic information without a doctor's prescription. The market's scope is being further expanded by significant investments in reproductive health testing, oncology genetics, and personalized medicine.

The market for hereditary genetic testing is expected to grow steadily as long as Europe prioritizes precision medicine and early disease detection. This growth will be aided by technological advancements, harmonized regulations, and rising public awareness.

Market Segmentation:

Segmentation 1: by Genetic Testing Type

• Oncology Genetic Testing
• Cardiology Genetic Testing
• Neurology Genetic Testing
• Newborn Screening
• Prenatal Screening (NIPT) and Preimplantation Testing
• Rare Disease Testing
• Direct-to-consumer (DTC) Testing

Segmentation 2: by Region

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Netherlands
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe hereditary genetic testing market has been extensively segmented based on various categories, such as genetic testing type and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments.

Competitive Strategy: The Europe hereditary genetic testing market has numerous established players with product portfolios. Key players in the Europe hereditary genetic testing market analyzed and profiled in the study involve established players offering products for hereditary genetic testing.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Centogene AG
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd

Table of Contents

Executive Summary

Scope and Definition

1 Hereditary Genetic Testing: Industry Outlook

• 1.1 Current State of Hereditary Genetic Testing
• 1.2 Market Footprint and Future Potential
• 1.3 Trends: Current and Future Impact Assessment
  • 1.3.1 Increasing Demand for Direct-to-consumer Testing
  • 1.3.2 Increasing Launch of Innovative Products and Regulatory Approvals in Genetic Testing Ecosystem
• 1.4 R&D Review
  • 1.4.1 Patent Filing Trend (by Year, Country)
• 1.5 Total Addressable Market and Penetration
• 1.6 Legal and Regulatory Framework
  • 1.6.1 Europe
    • 1.6.1.1 Germany
    • 1.6.1.2 France
    • 1.6.1.3 Italy
• 1.7 Reimbursement Scenario
• 1.8 Market Dynamics
  • 1.8.1 Market Drivers
    • 1.8.1.1 Rising Prevalence of Genetic Disorders along with Rare Diseases
    • 1.8.1.2 Increasing Inorganic Growth Activities in the Field of Hereditary Genetic Testing
    • 1.8.1.3 Increasing Number of Hereditary Genetic Tests
  • 1.8.2 Market Restraints
    • 1.8.2.1 High Cost Associated with Testing
    • 1.8.2.2 Shortage of Genetic Counselors
  • 1.8.3 Market Opportunities
    • 1.8.3.1 Expansion into Emerging Markets

2 Region

• 2.1 Drivers and Restraints
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 France
  • 2.2.5 Germany
  • 2.2.6 U.K.
  • 2.2.7 Spain
  • 2.2.8 Netherlands
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Landscape
  • 3.1.1 Key Strategies and Development
    • 3.1.1.1 Mergers and Acquisitions
    • 3.1.1.2 Product Launches
    • 3.1.1.3 Synergistic Activities
    • 3.1.1.4 Business Expansion Activities and Others
  • 3.1.2 Company Share Analysis
• 3.2 Company Profiles
  • 3.2.1 Centogene AG
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products/Product Portfolio
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Eurofins Scientific SE
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View
  • 3.2.3 F. Hoffmann-La Roche Ltd
    • 3.2.3.1 Top Products
    • 3.2.3.2 Top Competitors
    • 3.2.3.3 Key Personnel
    • 3.2.3.4 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast
• 4.3 Criteria for Company Profiling

List of Figures

• Figure 1: Hereditary Genetic Testing Market, by Region, $Billion, 2023, 2027, and 2033
• Figure 2: Europe Hereditary Genetic Testing Market (by Testing Type), $Billion, 2023 and 2033
• Figure 3: Key Events to Keep Track of in the Hereditary Genetic Testing Market
• Figure 4: Types of Hereditary Genetic Tests
• Figure 5: Hereditary Genetic Testing Market, Patent Analysis (by Year), January 2021-April 2024
• Figure 6: Hereditary Genetic Testing Market, Patent Analysis (by Country), January 2021-April 2024
• Figure 7: Europe Hereditary Genetic Testing Market Scenario, 2023
• Figure 8: Analysis of Market Navigating Factors, 2024-2033
• Figure 9: Rising Prevalence of Genetic Disorders
• Figure 10: Prevalence of a Few Rare Diseases
• Figure 11: Few Major Inorganic Growth Activities in the Hereditary Genetic Testing Market
• Figure 12: Number of Hereditary Genetic Tests Registered on Genetic Testing Registry, by Year
• Figure 13: Need for More Genetic Counselors
• Figure 14: Key Expansions in the Past Few Years
• Figure 15: France Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 16: Germany Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 17: U.K. Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 18: Spain Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 19: Netherlands Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 20: Rest-of-Europe Hereditary Genetic Testing Market, $Billion, 2022-2033
• Figure 21: Number of Mergers and Acquisitions (by Company), January 2021-April 2024
• Figure 22: Number of Product Launches (by Company), January 2021-April 2024
• Figure 23: Synergistic Activities Share (by Company), January 2021-April 2024
• Figure 24: Business Expansion Activities Share (by Company), January 2021-April 2024
• Figure 25: Hereditary Genetic Testing Market, Company Revenue Share Analysis, $Billion, 2023
• Figure 26: Data Triangulation
• Figure 27: Top-Down and Bottom-Up Approach
• Figure 28: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Hereditary Genetic Testing Market, Product Launches and Regulatory Approvals
• Table 4: Regulatory Bodies Governing Hereditary Genetic Testing
• Table 5: Europe Hereditary Genetic Testing Market (by Genetic Testing Type), $Billion, 2022-2033